Legal & General is getting into the U.S. life science property game. By putting up $500 million and allying with Ancora, the U.K. insurer is aiming to spark a five-year, $4 billion property blitz outside of the biotech hot spots.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,